CD44 and neoplasm: Prince and co-workers published the first report with evidence of CSCs in HNC when they identified a CD44+ population from primary human head and neck cancers that was tumorigenic in nude mice, could be serially passaged, and recapitulated the heterogeneity of the original human tumor [34].